Ives Jeffrey L.

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
17
Insider Sells Sum
$1.19M

Insider Activity of Ives Jeffrey L.

The largest sale of all time was on 2023-08-17 and amounted to 41949 shares of Acumen Pharmaceuticals, Inc. for $272,334.

Biography of Ives Jeffrey L.

No biography is available at this moment.

2023-08-17SaleAcumen Pharmaceuticals, Inc.
ABOS
director
41,949
0.0739%
$6.49$272,334-46.8%
2022-07-15SaleCara Therapeutics, Inc.
CARA
3,600
0.0066%
$9.05$32,580+4.76%
2021-11-12SaleCara Therapeutics, Inc.
CARA
director
8,180
0.0159%
$16.04$131,207-35.32%
2021-06-07SaleCara Therapeutics, Inc.
CARA
director
2,520
0.0049%
$13.05$32,886-6.38%
2020-11-19SaleCara Therapeutics, Inc.
CARA
director
2,500
0.0052%
$15.75$39,373-5.37%
2020-06-01SaleCara Therapeutics, Inc.
CARA
director
1,000
0.0022%
$16.00$16,000+2.2%
2020-05-12SaleCara Therapeutics, Inc.
CARA
director
2,500
0.0056%
$16.00$40,000+6.61%
2020-04-21SaleCara Therapeutics, Inc.
CARA
director
2,500
0.0055%
$16.00$40,000+3.92%
2020-03-04SaleCara Therapeutics, Inc.
CARA
director
2,500
0.0054%
$16.00$40,000-2.98%
2020-02-03SaleCara Therapeutics, Inc.
CARA
director
5,000
0.0086%
$13.09$65,425-5.46%
2020-01-02SaleCara Therapeutics, Inc.
CARA
director
5,000
0.009%
$13.04$65,175-0.45%
2019-12-02SaleCara Therapeutics, Inc.
CARA
director
5,000
0.0064%
$15.57$77,875-39.45%
2019-11-01SaleCara Therapeutics, Inc.
CARA
director
5,000
0.0066%
$13.00$65,000-24.63%
2019-10-01SaleCara Therapeutics, Inc.
CARA
director
5,000
0.007%
$11.77$58,825-8.99%
2019-09-03SaleCara Therapeutics, Inc.
CARA
director
5,000
0.0071%
$14.31$71,575-26.29%
2019-08-01SaleCara Therapeutics, Inc.
CARA
director
5,000
0.007%
$14.28$71,400-25.84%
2019-07-01SaleCara Therapeutics, Inc.
CARA
director
5,000
0.0068%
$13.54$67,675-23.92%
Company
About Prismo.proPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.